Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Standard 1910.1450 requires labs to have a chemical hygiene plan.
Approaching laboratory safety from a diversity, equity, inclusion, and accessibility perspective.
Artificial intelligence models have a valuable role to play in each phase of the total testing process.
With US STI cases continuing to climb to numbers not seen in decades, a recent FDA approval comes at an opportune moment.
While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.
The basics of how the OSHA inspection process works and how laboratories can successfully navigate it.
Genomic epidemiology can provide insights into pathogen transmission and evolution—and facilitate better countermeasures against infectious disease.
Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.